Moek, K. L
8  Ergebnisse:
Personensuche X
?
1

Phase I study of AMG 211/MEDI-565 administered as continuou..:

Moek, K. L ; Fiedler, W. M ; von Einem, J. C...
Moek , K L , Fiedler , W M , von Einem , J C , Verheul , H M , Seufferlein , T , de Groot , D J , Heinemann , V , Kebenko , M , Menke-van der Houven van Oordt , C W , Ettrich , T J , Rasmussen , E , Bogner , P , Sable , B , Stienen , S & de Vries , E G E 2018 , ' Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma ' , Annals of oncology : official journal of the European Society for Medical Oncology , vol. 29 , pp. viii139-viii140 . https://doi.org/10.1093/annonc/mdy279.414.  , 2018
 
?
2

Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE..:

Moek, K. L ; Waaijer, S. J.H ; Kok, I. C...
Moek , K L , Waaijer , S J H , Kok , I C , Suurs , F V , Brouwers , A , Menke-van der Houven van Oordt , C W , Wind , T T , Gietema , J A , Schroder , C P , Mahesh , S V K , Jorritsma-Smit , A , Lub-De Hooge , M N , Fehrmann , R S N , de Groot , D J & de Vries , E G E 2018 , ' Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE®) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas ' , Annals of oncology : official journal of the European Society for Medical Oncology , vol. 29 , pp. viii139 . https://doi.org/10.1093/annonc/mdy279.413.  , 2018
 
?
3

The antibody-drug conjugate target landscape across a broad..:

Moek, K. L ; de Groot, D. J. A ; de Vries, E. G. E.
https://research.rug.nl/en/publications/63b5355a-5f39-4d65-bde8-cb25e403c62c.  , 2017
 
?
7

Zr-89-labeled Bispecific T-cell Engager AMG 211 PET Shows A..:

Moek, Kirsten L ; Waaijer, Stijn J H ; Kok, Iris C...
https://research.rug.nl/en/publications/847e9ed8-03a1-423a-afec-1517d6324580.  , 2019
 
1-8